Rhamnose is an investigational drug.
There have been 3 clinical trials for Rhamnose.
The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2013.
The most common disease conditions in clinical trials are Crohn Disease, Malnutrition, and Premature Birth. The leading clinical trial sponsors are Dhaka Medical College, University of Virginia, and University of Washington.